Which Danish pharmaceutical company makes the diabetes drug Ozempic?

Novo Nordisk makes Ozempic, a prescription medicine containing the active ingredient semaglutide.

Ozempic is approved for adults with type 2 diabetes, where it is used with diet and exercise to improve blood-sugar control. Semaglutide belongs to the GLP-1 receptor agonist class, which imitates a hormone involved in glucose regulation and appetite. The drug is administered by injection.

Novo Nordisk developed a wider semaglutide portfolio. Wegovy is a higher-dose semaglutide product approved in several markets for chronic weight management, while Rybelsus is an oral semaglutide medicine for type 2 diabetes. Approval and labeling can differ by country.

Ozempic is often confused with Eli Lilly's Mounjaro and Zepbound, which contain tirzepatide rather than semaglutide. Rising demand for Novo Nordisk's medicines helped make the company one of Europe's most valuable public companies by market capitalization.